Follow the Telo Genomics Corp. stock price and the full insider trade history of the company, a listed issuer based in Canada. Shares trade on the CA market, under the oversight of SEDI. Market capitalisation: €5m. The latest transaction was filed on 7 August 2026 (50 - Grant of options). Among the most active insiders: Price, John. All data is openly available.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Telo Genomics Corp. es una empresa de biotecnología centrada en el desarrollo de pruebas de diagnóstico basadas en la telomerasa para el cáncer. Cotiza en la XTSE.